Revolutionising Skin Cancer Diagnosis: From pilot success to long term sustainability in secondary care
24 Apr 2024
Data, Analytics & Applied AI Theatre
This talk will explore the journey of a pioneering skin cancer AI company that has transitioned from successful pilots to scalable implementation in secondary care settings. Our NHS Partner wil provide insights into the real-world impact on patient outcomes and the efficiency gains experienced by implementing DERM, AIaMD into their skin cancer pathway.
We'll navigate through the challenges and successes of this journey, whilst also addressing the opportunity it provides as a proven sustainable solution to reducing caseload for dermatology teams, during a time when skin cancer referrals are at their highest and increasing 11% year on year.